E-nitiate Biopharmaceuticals Funding: $14M Raised, Series A
E-nitiate Biopharmaceuticals has raised $14M in total funding. Latest round: Series A. Backed by Time Investment, Taikun Fund, Linping State Investment.
E-nitiate Biopharmaceuticals funding overview
E-nitiate Biopharmaceuticals has raised $14M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in April 2023. The round record for E-nitiate Biopharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund. 4 distinct backers are named across the disclosed rounds.
E-nitiate Biopharmaceuticals at a glance
Total raised
$14M
Latest round
Series A
Latest round date
April 2023
Notable investors
Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund
Frequently asked about E-nitiate Biopharmaceuticals funding
How much has E-nitiate Biopharmaceuticals raised?
E-nitiate Biopharmaceuticals has raised $14M in total disclosed funding across the rounds on record.
Who has invested in E-nitiate Biopharmaceuticals?
Time Investment, Taikun Fund, Linping State Investment, Hangzhou Golden Investment Industry Fund are named among the investors backing E-nitiate Biopharmaceuticals.
What was the latest E-nitiate Biopharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in April 2023.
Where is E-nitiate Biopharmaceuticals based?
No headquarters location is disclosed for E-nitiate Biopharmaceuticals.
When did E-nitiate Biopharmaceuticals last raise?
The last disclosed E-nitiate Biopharmaceuticals round closed in April 2023 at Series A.
Every E-nitiate Biopharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.
Companies related to E-nitiate Biopharmaceuticals (30)
